Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +1 |
| Ticker | SNPX |
| Latest Price | 8.50 USD as of close on 03-Jul-2025 |
| 3 Month price range | 2.05 to 8.50 USD |
| Market Capitalisation | 10.91Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Synaptogenix, Inc. operates as a biopharmaceutical company. The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing. The company was incorporated in 2012 and is headquartered in New York, New York. See More ... |
| Company URL | https://www.synaptogen.com |
| See Darwins Full Analysis for Synaptogenix Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Synaptogenix Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +21 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +2 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -22 |
There are 5 live alerts for Synaptogenix Inc.
There are 6 peers of Synaptogenix Inc.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc (CPRX) | Biotechnology | -15.1 | +23 |
| Elevation Oncology Inc (ELEV) | Biotechnology | +27.5 | -5 |
| Revelation Biosciences Inc (REVB) | Biotechnology | -14.1 | -19 |
| TG Therapeutics Inc (TGTX) | Biotechnology | -0.9 | +34 |
| Vaxart Inc (VXRT) | Biotechnology | +5.7 | -16 |
| Windtree Therapeutics Inc (WINT) | Biotechnology | +38.7 | -21 |
To see complete information on Synaptogenix Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |